Product NDC: | 0781-3040 |
Proprietary Name: | Regonol |
Non Proprietary Name: | Pyridostigmine Bromide |
Active Ingredient(s): | 5 mg/mL & nbsp; Pyridostigmine Bromide |
Administration Route(s): | INTRAVENOUS; PARENTERAL |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0781-3040 |
Labeler Name: | Sandoz Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA017398 |
Marketing Category: | NDA |
Start Marketing Date: | 20050510 |
Package NDC: | 0781-3040-95 |
Package Description: | 10 AMPULE in 1 CARTON (0781-3040-95) > 2 mL in 1 AMPULE (0781-3040-72) |
NDC Code | 0781-3040-95 |
Proprietary Name | Regonol |
Package Description | 10 AMPULE in 1 CARTON (0781-3040-95) > 2 mL in 1 AMPULE (0781-3040-72) |
Product NDC | 0781-3040 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Pyridostigmine Bromide |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS; PARENTERAL |
Start Marketing Date | 20050510 |
Marketing Category Name | NDA |
Labeler Name | Sandoz Inc |
Substance Name | PYRIDOSTIGMINE BROMIDE |
Strength Number | 5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |